James R. Empfield - Net Worth and Insider Trading
James R. Empfield Net Worth
The estimated net worth of James R. Empfield is at least $433,600 dollars as of 2024-11-13. James R. Empfield is the EVP, Drug Discovery of Xenon Pharmaceuticals Inc and owns about 10,000 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $433,600. Details can be seen in James R. Empfield's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James R. Empfield has not made any transactions after 2022-08-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James R. Empfield
James R. Empfield Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James R. Empfield owns 1 companies in total, including Xenon Pharmaceuticals Inc (XENE) .
Click here to see the complete history of James R. Empfield’s form 4 insider trades.
Insider Ownership Summary of James R. Empfield
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2022-08-12 | SVP & Drug Discovery |
James R. Empfield Latest Holdings Summary
James R. Empfield currently owns a total of 1 stock. James R. Empfield owns 10,000 shares of Xenon Pharmaceuticals Inc (XENE) as of August 12, 2022, with a value of $433,600.
Latest Holdings of James R. Empfield
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2022-08-12 | 10,000 | 43.36 | 433,600 |
Holding Weightings of James R. Empfield
James R. Empfield Form 4 Trading Tracker
According to the SEC Form 4 filings, James R. Empfield has made a total of 2 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 57,743 shares on August 12, 2022, which brought James R. Empfield around $2 Million.
Insider Trading History of James R. Empfield
- 1
James R. Empfield Trading Performance
GuruFocus tracks the stock performance after each of James R. Empfield's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James R. Empfield is -10.2%. GuruFocus also compares James R. Empfield's trading performance to market benchmark return within the same time period. The performance of stocks bought by James R. Empfield within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James R. Empfield's insider trading performs compared to the benchmark.
Performance of James R. Empfield
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 28.57 | | | | | |
| Relative Return to S&P 500(%) | 27.12 | | | | | |
James R. Empfield Ownership Network
Ownership Network List of James R. Empfield
Ownership Network Relation of James R. Empfield
James R. Empfield Owned Company Details
What does Xenon Pharmaceuticals Inc do?
Who are the key executives at Xenon Pharmaceuticals Inc?
James R. Empfield is the SVP & Drug Discovery of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include SVP Bus. & Corp. Development Sherrington Robin , director & PRESIDENT & CEO Ian Mortimer , and Chief Medical Officer Christopher John Kenney .
Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary
Over the past 18 months, James R. Empfield made no insider transaction in Xenon Pharmaceuticals Inc (XENE). Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 26,576 shares made by Gary Patou , a net sale of 131,245 shares made by Simon N. Pimstone , and a net sale of 31,655 shares made by Ian Mortimer .
In summary, during the past 3 months, insiders sold 0 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 236,705 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 236,705 shares.
Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xenon Pharmaceuticals Inc Insider Transactions
James R. Empfield Mailing Address
Above is the net worth, insider trading, and ownership report for James R. Empfield. You might contact James R. Empfield via mailing address: 200 - 3650 Gilmore Way, Burnaby A1 Vg5 48w.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
